pSivida stock rises after being named as a takeover target
June 17, 2013 at 14:09 PM EDT
Stock in pSivida Corp. (Nasdaq: PSDV) rose 9 percent Monday after its treatment for some types of chronic diabetic macular edema (DME) was deemed cost effective by a UK agency, and the company was mentioned as a posible takeover target...
